Min Zhang

机构：Shanghai Medical College of Fudan University, Jinan University, Shanghai Jiao Tong University, Huadong Hospital, China Institute of Veterinary Drug Control, The Affiliated Yongchuan Hospital of Chongqing Medical University, Shanghai First People's Hospital, Shenzhen Luohu People's Hospital, Yunnan University of Traditional Chinese Medicine, Chongqing Medical University · ORCID：0000-0002-5491-943X

发表论文 129 篇 · 总被引 1921 次 · h-index 25

代表论文

• Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle‐aged and older populations: Insights from the China health and retirement longitudinal study (2024 · Diabetes/Metabolism Research and Reviews · 被引 79)
• The Scap-SREBP1-S1P/S2P lipogenesis signal orchestrates the homeostasis and spatiotemporal activation of NF-κB (2023 · Cell Reports · 被引 41)
• Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study (2025 · The Lancet Respiratory Medicine · 被引 38)
• Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer (2023 · Journal of Pharmaceutical and Biomedical Analysis · 被引 15)
• Carryover Contamination-Controlled Amplicon Sequencing Workflow for Accurate Qualitative and Quantitative Detection of Pathogens: a Case Study on SARS-CoV-2 (2023 · Microbiology Spectrum · 被引 9)
• A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution forPseudomonas aeruginosaeradication in bronchiectasis: ERASE (2024 · ERJ Open Research · 被引 8)